Skip to main content

Alcohol Use Disorders in Primary Care - .25 CME Credits

Screening, educating, and treating patients regarding alcohol use

Start Date: December 12, 2017
Duration: ~25 min.
Price: $15

Course Description

Join respected Boston psychiatrist and HMS instructor Dr. David Wolfe as he updates his colleagues on the latest guidelines regarding alcohol use disorder (AUD). In his presentation, Dr. Wolfe reviews current prevalence data, co-morbidities, and screening methods as well as changes reflected in the DSM-5 concerning the categorization of at-risk drinking behaviors.

This course focuses on patient education and intervention, and it provides up-to-date information on pharmacological agents used in treating AUD. It is intended for primary care physicians and others interested in learning more about identifying, educating, and treating patients regarding safe alcohol use and AUD.

Dr. Wolfe's presentation can also be found in our comprehensive internal medicine and board review course, Update and Board Review in Internal Medicine: Part Two.

What You'll Learn

  • Identify where patients lie along the spectrum of alcohol use risk categories described in the DSM-5
  • Educate patients about safe drinking limits, behavior modification strategies, and available interventions


Dr. David Wolfe, MD

Dr. David Wolfe, MD Instructor in Psychiatry, Harvard Medical School; Director of Outpatient Services, Associate Vice Chair, Department of Psychiatry, Brigham and Women's Hospital


Alcohol Use Disorders in Primary Care is organized as follows:

Precourse Information:
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Viewing Videos
Grading and Certificates

Alchol Use Disorders in Primary Care
A Lecture by Dr. David Wolfe

CME Certificate
CME Posttest
Course Evaluation



The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The Harvard Medical School designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

All individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.


Dr. Martina M. McGrath, MB, BCh, FASN is an instructor in medicine at Harvard Medical School. She is also an associate physician and attending nephrologist at Brigham and Women’s Hospital.

Dr. McGrath completed her medical degree, internal medicine residency, and nephrology training in Ireland. She then completed the Brigham and Women’s Hospital/Massachusetts General Hospital nephrology fellowship program and joined faculty at BWH and HMS in 2012.

Her subspecialty interest is in transplant nephrology, and she is an investigator in basic transplant immunology, based at the Transplantation Research Center, BWH. Her research is focused on targeting T cell costimulatory pathways in allograft rejection, and developing novel therapies to target these pathways and promote the development of regulatory T cells and allograft tolerance. She also is active in the area of medical education, serving as course director for the combined BWH/HMS Update in Internal Medicine series of courses.

View Dr. McGrath's profile.


Dr. Adam Schaffer graduated from Yale College magna cum laude and received his MD from the University of Pennsylvania School of Medicine. He completed his internship in internal medicine at the Hospital of the University of Pennsylvania, and then his residency in internal medicine at Columbia-Presbyterian Medical Center. After residency, Adam spent a year working as a hospitalist at Massachusetts General Hospital, before completing a fellowship in nephrology at Weill-Cornell Medical Center. Affiliated with Brigham and Women’s Hospital for the last nine years, Adam currently works as an attending physician on the hospital medicine unit, where he is director of the general medicine consultation service. Adam is also an instructor at Harvard Medical School.


How long will this course take?

This course should take approximately 25 minutes to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.